RNL Bio and Human Biostar to Offer Direct-to-Consumer Adult Stem Cell Banking in the United States
5/21/2013 9:30:58 AM
More...
|
RNL Bio Files IND to Commence Phase II Clinical Trial of RNL-JointStem for Osteoarthritis in the United States
5/2/2013 11:09:42 AM
More...
|
RNL Bio Filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
2/11/2013 8:57:38 AM
More...
|
RNL Bio Study Shows Stem Cells May Prevent and Cure Alzheimer's
9/27/2012 8:19:29 AM
More...
|
RNL Bio, a South Korean Adult Stem Cell Firm, Introduces Its Autologous Stem Cell Therapeutics in Turkey to Treat Patients With Various Intractable Diseases
9/14/2012 10:52:27 AM
More...
|
RNL Bio Release: New Method Helps Stem Cells Find Damaged Tissue Better
11/17/2011 10:58:00 AM
More...
|
RNL Bio Release: American Orthopedic Spine Surgeon Successfully Treated for Autoimmune Arthritis with His Own Stem Cells
1/27/2011 7:30:37 AM
More...
|
RNL Bio and stART Licensing, Inc. Settled Patent Disputes and Concluded a License Agreement
1/12/2010 8:33:40 AM
More...
|
RNL Bio Rescues a College Student from Autoimmune Hearing Loss
11/4/2009 8:58:58 AM
More...
|
South Korean Bio-Firm, RNL Bio Says Dog Cloning to be Cheaper
1/29/2009 8:34:56 AM
More...
|
|